JPMorgan Upgrades Agios Pharma (AGIO) to Overweight
Tweet
Share
E-mailGet Alerts AGIO Hot Sheet
Price: $31.67 --0%
Rating Summary:
15 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
15 Buy, 7 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
JPMorgan upgraded Agios Pharma (NASDAQ: AGIO) from Neutral to Overweight with a price target of $55.00 (from $40.00).
For an analyst ratings summary and ratings history on Agios Pharma click here. For more ratings news on Agios Pharma click here.
Shares of Agios Pharma closed at $35.48 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tyler Tech (TYL) PT Raised to $500 at Oppenheimer
- Comcast Corp (CMCSA) PT Lowered to $48 at Pivotal Research
- Merck (MRK) PT Raised to $143 at Truist Securities
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
